Sugentech, Inc. Logo

Sugentech, Inc.

Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.

253840 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노2로 206 사무동2층 수젠텍, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Sugentech, Inc. is an in-vitro diagnostic (IVD) company that develops and commercializes next-generation diagnostic products by integrating biotechnology (BT), nanotechnology (NT), and information technology (IT). The company specializes in immunochemical diagnostics, leveraging its proprietary platforms for high-level antibody development and high-sensitivity immunoassay technologies. Sugentech offers a range of diagnostic systems tailored to various healthcare settings: multi-immunoblot automation systems for hospitals and medical centers, point-of-care testing (POCT) for smaller clinics, and mobile health (m-Health) solutions for personal, at-home use. Its products are designed for the diagnosis of conditions such as infectious diseases, cardiovascular diseases, and diabetes, aiming to provide personalized and accessible digital healthcare solutions.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Sugentech, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-08 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 35.7 KB
2025-09-08 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 6.2 KB
2025-08-29 00:00
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
Korean 53.4 KB
2025-08-29 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 42.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB

Automate Your Workflow. Get a real-time feed of all Sugentech, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Sugentech, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland LONN
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway LYTIX
MaaT Pharma Logo
Developing gut microbiome therapies to improve survival for cancer patients.
France MAAT
Mabion S.A. Logo
Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.
Poland MAB
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden MAGLE
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany N/A
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria MARI
Matricelf Ltd. Logo
Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.
Israel MTLF
Median Diagnostics Inc. Logo
Manufactures veterinary IVD kits & raw materials to diagnose infectious animal diseases.
South Korea 233250
MediciNova,Inc. Logo
Developing small-molecule drugs for neurology, respiratory, and liver diseases.
Japan 4875

Talk to a Data Expert

Have a question? We'll get back to you promptly.